[NBIX] QoQ Quarter Result on 31-Mar-2019 [#Q1]

Stock
[NBIX] Neurocrine Biosciences, Inc.
Announcement Date
29-Apr-2019
Financial Year
2019
Quarter
31-Mar-2019 [#Q1]
Profit Trend
QoQ- -664.86%
YoY- -144.19%
Quarter Report
NBIX's Result
NBIX's Financial Summary
View:
Show?
Quarter Result
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
Revenue 244,100 222,094 183,580 138,403 131,492 151,757 96,905 84.82%
PBT 38,600 58,407 52,091 -102,594 18,808 50,764 -5,913 -
Tax 4,600 4,618 753 -479 730 7,672 7,591 -28.32%
NP 34,000 53,789 51,338 -102,115 18,078 50,764 -5,913 -
Tax Rate -11.92% -7.91% -1.45% - -3.88% -15.11% - -
Total Cost 210,100 168,305 132,242 240,518 113,414 100,993 102,818 60.81%
Ratio Analysis
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
NP Margin 13.93 24.22 27.96 -73.78 13.75 33.45 -6.10 -
Per Share
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
EPS 0.37 0.59 0.56 -1.12 0.20 0.56 -0.07 -
EPS Diluted 0.35 0.56 0.54 -1.12 0.19 0.52 -0.07 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.